A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Oncologist Dr. Sarah Cate told Newsweek: "Many women simply don't make time for themselves, since they are working and often ...

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

Aging research has experienced substantial advancements in the past decade, particularly in understanding the interrelation ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential for other cancers as well. Scientists led by ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Scientists who rely on federal grants for vital research have been left 'panicking' due to the President's threats over ...

U.S. Rep. Don Beyer of Virginia led 89 of his colleagues in decrying attacks on the NIH that endanger vitally important medical research.

TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.